Arca
Skip to content
Tools
Tools

Trypanosomiasis

Drug research and approvals for trypanosomiasis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 20, 2026, 4 studies of trypanosomiasis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 3 approved and 2 open orphan designations naming it.

  • Recruiting worldwide: 4
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 3
  • EU medicines: 0

Recruiting now

Newest posted first, of 4 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 8

Phase 3 4

Phase 2 1

Phase 1 or earlier 3

  • MidazolamGABA-A receptor; anion channel positive allosteric modulator
  • DextromethorphanSigma opioid receptor agonist
  • AcoziboroleCleavage and polyadenylation specificity factor subunit inhibitor

How its trials ended

32 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 14 whose ending is known, 57% met their primary endpoint, 7% missed it and 36% stopped early.

  • Completed, result not reported1444%
  • Met its primary endpoint825%
  • Stopped: other or unclear39%
  • Ongoing26%
  • Status unknown26%
  • Missed its primary endpoint13%
  • Stopped: lack of efficacy13%
  • Stopped: enrollment or feasibility13%

FDA orphan designations

Approved first, then open designations, newest first
Jul 16, 2021FexinidazoleTreatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to…Sanofi US Services Inc., A SANOFI COMPANYApproved
Aug 6, 2020LampitLAMPIT is indicated in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas…Bayer HealthCare Pharmaceuticals, Inc.Approved
Aug 29, 2017BenznidazoleTreatment of Chagas disease (American trypanosomiasis), caused by Trypanosoma cruzi, in pediatric patients 2 to 12 years of age.Chemo Research, S.L.Approved
Jan 25, 2021SuraminTreatment of human African trypanosomiasisPaxMedica, Inc.Designated
Aug 31, 2007Pafuramidine maleateTreatment of human African trypanosomiasis (sleeping sickness)Immtech Pharmaceuticals, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.